Fiebig HH - Search Results

1

Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.

Licht T, Lübbert M, Martens C, Bross KJ, Fiebig HH, Mertelsmann R, Herrmann F. Licht T, et al. Among authors: fiebig hh. Cytokines Mol Ther. 1995 Jun;1(2):123-32. Cytokines Mol Ther. 1995. PMID: 9384669

2

Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.

Licht T, Bross KJ, Fiebig HH, Schötta K, Berger DP, Dreher C, Löhr GW, Herrmann F. Licht T, et al. Among authors: fiebig hh. J Cancer Res Clin Oncol. 1992;118(2):116-22. doi: 10.1007/BF01187499. J Cancer Res Clin Oncol. 1992. PMID: 1735731

3

Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro.

Licht T, Fiebig HH, Bross KJ, Herrmann F, Berger DP, Shoemaker R, Mertelsmann R. Licht T, et al. Among authors: fiebig hh. Int J Cancer. 1991 Oct 21;49(4):630-7. doi: 10.1002/ijc.2910490427. Int J Cancer. 1991. PMID: 1917165

4

Effects of human bone marrow stroma on the growth of human tumor cells.

Strobel ES, Strobel HG, Bross KJ, Winterhalter B, Fiebig HH, Schildge JU, Löhr GW. Strobel ES, et al. Among authors: fiebig hh. Cancer Res. 1989 Feb 15;49(4):1001-7. Cancer Res. 1989. PMID: 2912545

5

Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays.

Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH. Dengler WA, et al. Among authors: fiebig hh. Anticancer Drugs. 1995 Aug;6(4):522-32. doi: 10.1097/00001813-199508000-00005. Anticancer Drugs. 1995. PMID: 7579556

6

Cytotoxicity of TGF alpha-PE40 and correlation to expression of epidermal growth factor receptor.

Berger DP, Herbstritt L, Hellerich U, Schulzke S, Dengler WA, Gallo M, Pastan I, Mertelsmann R, Fiebig HH. Berger DP, et al. Among authors: fiebig hh. Eur J Cancer. 1995 Nov;31A(12):2067-72. doi: 10.1016/0959-8049(95)00422-x. Eur J Cancer. 1995. PMID: 8562167

7

Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies.

Berger DP, Herbstritt L, Dengler WA, Marmé D, Mertelsmann R, Fiebig HH. Berger DP, et al. Among authors: fiebig hh. Ann Oncol. 1995 Oct;6(8):817-25. doi: 10.1093/oxfordjournals.annonc.a059322. Ann Oncol. 1995. PMID: 8589021 Free article.

8

Processing of tumor tissues for vaccination with autologous tumor cells.

Lahn M, Köhler G, Schmoor C, Dengler W, Veelken H, Brennscheidt U, Mackensen A, Kulmburg P, Hentrich I, Jesuiter H, Rosenthal FM, Fiebig HH, Sommerkamp H, Farthmann EH, Hasse J, Mertelsmann R, Lindemann. Lahn M, et al. Among authors: fiebig hh. Eur Surg Res. 1997;29(4):292-302. doi: 10.1159/000129536. Eur Surg Res. 1997. PMID: 9257102

9

Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model.

Wehr C, Müller F, Schüler J, Tomann T, Nitschke C, Seismann H, Spillner E, Klingner K, Schneider-Merck T, Binder M, Fiebig HH, Mertelsmann R, Trepel M. Wehr C, et al. Among authors: fiebig hh. Int J Cancer. 2012 Jul 15;131(2):E10-20. doi: 10.1002/ijc.26464. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 21953178

10

Preclinical activity of hepsulfam and busulfan in solid human tumor xenografts and human bone marrow.

Berger DP, Winterhalter BR, Dengler WA, Fiebig HH. Berger DP, et al. Among authors: fiebig hh. Anticancer Drugs. 1992 Oct;3(5):531-9. doi: 10.1097/00001813-199210000-00014. Anticancer Drugs. 1992. PMID: 1450448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters